Contineum Therapeutics Inc - Class A Common Stock

NEW
NAS:CTNM (USA)   Class A Common Stock
$ 15.46 -0.21 (-1.37%) 10:10 PM EST
At Loss
P/B:
2.32
Market Cap:
$ 581.43M
Enterprise V:
$ 339.74M
Volume:
448.51K
Avg Vol (2M):
362.91K
Trade In:
Volume:
448.51K
At Loss
Avg Vol (2M):
362.91K

Contineum Therapeutics Inc (CTNM) Dividend

Contineum Therapeutics Inc (CTNM) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -11.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: CTNM Dividend

Does Contineum Therapeutics Inc (CTNM) pay a dividend?

Contineum Therapeutics Inc (CTNM) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Contineum Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Contineum Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -11.3% over the past 3 years.

What are dividend-paying alternatives to Contineum Therapeutics Inc?

For dividend-paying alternatives in Contineum Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.